Egypt Ventures

Egypt Ventures is a government-backed catalytic investor that has played an outsized role in shaping Egypt’s startup ecosystem, with cheques in the $1M-$5M range across pre-seed, seed, and Series A. The firm is best understood as both a direct investor and an LP and co-investor in independent accelerators and managers, including notable healthcare alumni like Rology in radiology AI. The fund’s mandate covers Health IT, digital health, and AI/ML in healthcare and is explicitly aligned with national tech and economic development goals. The right founder is an Egyptian operator building a scalable health-tech or AI healthcare platform with regional ambitions across MENA, who can use Egypt Ventures as a domestic anchor while bringing in regional and international syndicate partners. Founders running deep biotech, US-only plays, or non-Egyptian ventures should not approach. Entry path is via Egypt Ventures’ direct portal, the Cairo founder community, or warm introductions from co-investing accelerators (Flat6Labs, A15) and regional funds (Sawari, Algebra). In the pitch, lead with regulatory pathway in Egypt’s MOHP and CAPMAS environment, hospital partnerships, Arabic-language localisation, and a credible plan to scale across the Gulf and Levant. Caveats: as a state-backed investor, Egypt Ventures’ processes can be procedurally heavy and term sheets may include reporting and impact commitments worth reviewing carefully. Egypt’s macroeconomic and currency volatility is a structural concern for founders raising in EGP, so plan FX-aware forecasting and international Series A leads. The fund’s AI focus is real but selective, so AI-heavy founders should be prepared to defend model claims with external technical advisors. Confirm reserves and current vintage explicitly during diligence to verify pacing.